{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:15:23Z","timestamp":1759814123448},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10014-018-0319-y","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T08:06:30Z","timestamp":1525853190000},"page":"181-185","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A case of epidural glioblastoma metastasis presenting with a cervical myelopathy, torticollis, and L\u2019hermitte\u2019s phenomenon"],"prefix":"10.1007","volume":"35","author":[{"given":"Michael W.","family":"Ruff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adip G.","family":"Bhargav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya","family":"Raghunathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"319_CR1","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1186\/1756-0500-6-290","volume":"6","author":"C Blume","year":"2013","unstructured":"Blume C, von Lehe M, van Landeghem F, Greschus S, Bostrom J (2013) Extracranial glioblastoma with synchronous metastases in the lung, pulmonary lymph nodes, vertebrae, cervical muscles and epidural space in a young patient\u2014case report and review of literature. BMC Res Notes 6:290","journal-title":"BMC Res Notes"},{"key":"319_CR2","doi-asserted-by":"publisher","first-page":"479","DOI":"10.3892\/mco.2015.494","volume":"3","author":"A Ray","year":"2015","unstructured":"Ray A, Manjila S, Hdeib AM et al (2015) Extracranial metastasis of gliobastoma: three illustrative cases and current review of the molecular pathology and management strategies. Mol Clin Oncol 3:479\u2013486","journal-title":"Mol Clin Oncol"},{"key":"319_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10143-015-0656-9","volume":"39","author":"E Anghileri","year":"2016","unstructured":"Anghileri E, Castiglione M, Nunziata R et al (2016) Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature. Neurosurg Rev 39:37\u201345 (discussion-6)","journal-title":"Neurosurg Rev"},{"key":"319_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/nop\/npv054","volume":"3","author":"KE Leaver","year":"2016","unstructured":"Leaver KE, Zhang N, Ziskin JL, Vogel H, Recht L, Thomas RP (2016) Response of metastatic glioma to vemurafenib. Neuro-Oncology Practice 3:268\u2013271","journal-title":"Neuro-Oncology Practice"},{"key":"319_CR5","doi-asserted-by":"publisher","first-page":"182985","DOI":"10.1155\/2015\/182985","volume":"2015","author":"A Lombard","year":"2015","unstructured":"Lombard A, Goffart N, Rogister B (2015) Glioblastoma circulating cells: reality, trap or illusion? Stem Cells Int 2015:182985","journal-title":"Stem Cells Int"},{"key":"319_CR6","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/nature00766","volume":"417","author":"H Davies","year":"2002","unstructured":"Davies H, Bignell GR, Cox C et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949\u2013954","journal-title":"Nature"},{"key":"319_CR7","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477","journal-title":"Cell"},{"key":"319_CR8","doi-asserted-by":"publisher","first-page":"e87-9","DOI":"10.1200\/JCO.2015.64.2777","volume":"34","author":"EQ Lee","year":"2016","unstructured":"Lee EQ, Ruland S, LeBoeuf NR, Wen PY, Santagata S (2016) Successful treatment of a progressive BRAF V600E-mutated anaplastic pleomorphic xanthoastrocytoma with vemurafenib monotherapy. J Clin Oncol 34:e87-9","journal-title":"J Clin Oncol"},{"key":"319_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13000-016-0506-2","volume":"11","author":"F Behling","year":"2016","unstructured":"Behling F, Barrantes-Freer A, Skardelly M et al (2016) Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Diagn Pathol 11:55","journal-title":"Diagn Pathol"},{"key":"319_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10014-015-0239-z","volume":"33","author":"N Funata","year":"2016","unstructured":"Funata N, Nobusawa S, Yamada R, Shinoura N (2016) A case of osteoclast-like giant cell-rich epithelioid glioblastoma with BRAF V600E mutation. Brain Tumor Pathol 33:57\u201362","journal-title":"Brain Tumor Pathol"},{"key":"319_CR11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996","journal-title":"N Engl J Med"},{"key":"319_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ et al (2015) Structural and functional features of central nervous system lymphatic vessels. Nature 523:337\u2013341","journal-title":"Nature"},{"key":"319_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.ccell.2017.02.009","volume":"31","author":"DF Quail","year":"2017","unstructured":"Quail DF, Joyce JA (2017) The microenvironmental landscape of brain tumors. Cancer Cell 31:326\u2013341","journal-title":"Cancer Cell"},{"key":"319_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/RCT.0b013e318076b472","volume":"32","author":"MA Fatt","year":"2008","unstructured":"Fatt MA, Horton KM, Fishman EK (2008) Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient. J Comput Assist Tomogr 32:407\u2013409","journal-title":"J Comput Assist Tomogr"},{"key":"319_CR15","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/01.TP.0000076094.64973.D8","volume":"76","author":"JF Buell","year":"2003","unstructured":"Buell JF, Trofe J, Sethuraman G et al (2003) Donors with central nervous system malignancies: are they truly safe? Transplantation 76:340\u2013343","journal-title":"Transplantation"},{"key":"319_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11060-015-1939-2","volume":"126","author":"T Dasgupta","year":"2016","unstructured":"Dasgupta T, Olow AK, Yang X et al (2016) Survival advantage combining a BRAF inhibitor and radiation in BRAF V600E-mutant glioma. J Neurooncol 126:385\u2013393","journal-title":"J Neurooncol"},{"key":"319_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/NEN.0b013e318279f3db","volume":"72","author":"C Horbinski","year":"2013","unstructured":"Horbinski C (2013) To BRAF or Not to BRAF: is that even a question anymore? J Neuropathol Exp Neurol 72:2\u20137","journal-title":"J Neuropathol Exp Neurol"},{"key":"319_CR18","doi-asserted-by":"crossref","first-page":"11882","DOI":"10.18632\/oncotarget.3592","volume":"6","author":"H Xu","year":"2015","unstructured":"Xu H, Rahimpour S, Nesvick CL et al (2015) Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapy. Oncotarget 6:11882\u201311893","journal-title":"Oncotarget"},{"key":"319_CR19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/neuonc\/nop027","volume":"12","author":"JF Groot de","year":"2010","unstructured":"de Groot JF, Fuller G, Kumar AJ et al (2010) Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice. Neuro Oncol 12:233\u2013242","journal-title":"Neuro Oncol"},{"key":"319_CR20","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1038\/bjc.2011.81","volume":"104","author":"F Fan","year":"2011","unstructured":"Fan F, Samuel S, Gaur P et al (2011) Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathways that mediate tumour cell migration. Br J Cancer 104:1270\u20131277","journal-title":"Br J Cancer"},{"key":"319_CR21","first-page":"503","volume":"19","author":"JM Ayuso","year":"2017","unstructured":"Ayuso JM, Monge R, Mart\u00ednez-Gonz\u00e1lez A et al (2017) Glioblastoma on a microfluidic chip: Generating pseudopalisades and enhancing aggressiveness through blood vessel obstruction events. Neuro-Oncol 19:503\u2013513","journal-title":"Neuro-Oncol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-018-0319-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-018-0319-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-018-0319-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T19:26:52Z","timestamp":1604258812000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-018-0319-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,9]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1007\/s10014-018-0319-y","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,9]]},"assertion":[{"value":"27 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}